mirtazapine has been researched along with Dyslipidemia in 3 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with mirtazapine, a widely prescribed antidepressant, has been linked to weight gain and dyslipidemia." | 4.31 | Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men. ( Dose, T; Fulda, S; Heel, S; Hennings, JM; Holsboer, F; Kloiber, S; Lechner, K; Lucae, S; Schaaf, L; Uhr, M, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Lechner, K | 1 |
Heel, S | 1 |
Uhr, M | 1 |
Dose, T | 1 |
Holsboer, F | 1 |
Lucae, S | 1 |
Schaaf, L | 1 |
Fulda, S | 1 |
Kloiber, S | 1 |
Hennings, JM | 1 |
Song, HR | 1 |
Woo, YS | 1 |
Wang, HR | 1 |
Shim, IH | 1 |
Jun, TY | 1 |
Bahk, WM | 1 |
Moffatt, A | 1 |
Ticehurst, S | 1 |
3 other studies available for mirtazapine and Dyslipidemia
Article | Year |
---|---|
Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men.
Topics: Antidepressive Agents; Cholesterol, HDL; Dyslipidemias; Fasting; Humans; Male; Mirtazapine; Triglyce | 2023 |
Does mirtazapine interfere with naturalistic diabetes treatment?
Topics: Antidepressive Agents, Tricyclic; Blood Glucose; Body Mass Index; Case-Control Studies; Cholesterol; | 2014 |
Mirtazapine-induced massive dyslipidaemia in an elderly woman.
Topics: Aged; Antidepressive Agents, Tricyclic; Dyslipidemias; Female; Humans; Mianserin; Mirtazapine | 2013 |